Drug – bio-affecting and body treating compositions – Immunoglobulin – antiserum – antibody – or antibody fragment,... – Monoclonal antibody or fragment thereof
Patent
1999-04-23
2000-10-10
Huff, Sheela
Drug, bio-affecting and body treating compositions
Immunoglobulin, antiserum, antibody, or antibody fragment,...
Monoclonal antibody or fragment thereof
4241301, 4241351, 4241411, 4241781, 4241831, 5303888, 53038885, 5303873, 5303881, 53038822, 53038824, A61K 39395
Patent
active
061299154
ABSTRACT:
The present invention is related to single and double chain antibodies to EGF receptor. The invention also relates to toxin conjugates of such antibodies. These antibodies are useful for treating and diagnosing the status of pathological conditions such as cancer and cellular hyper proliferation.
REFERENCES:
Gulick, British Medical Bulletin, 47:87-98, 1991.
Matsui et al., Cancer Research, 44:1002-1007, 1984.
Jian, Scientific American, 271:58-65, 1994.
Chatterjie et al., Cancer Immunol. Immunother., 38:75-82, 1994.
Gura et al., Science, 278:1041-1042, 1997.
Seaver, Genetic Engineering News, 14:10 and 21, 1994.
Lorimer et al., PNAS 93:14815-14820 (1996).
Wikstrand et al., Cancer Research 55:3140-3148 (1995).
Schmidt et al., Brit J. Cancer 75:1575-1584 (1997).
Wels et al., International Journal of Cancer, vol. 60, No. 1, pp. 137-144, Jan. 3, 1995.
Schmidt Mathias
Schneider Douglas W.
Vakalopoulou Evangelia
Wels Winfried S.
Helms Larry R.
Huff Sheela
Schering Aktiengesellschaft
LandOfFree
Epidermal growth factor receptor antibodies does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Epidermal growth factor receptor antibodies, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Epidermal growth factor receptor antibodies will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2254279